Before using this medication, tell your doctor or pharmacist your medical history, especially of: low potassium blood levels (hypokalemia), gout, a certain blood disorder (polycythemia vera), a certain eye disease (Leber's disease), other vitamin/mineral deficiencies (especially folic acid and iron)
Future therapies: Scientists are developing next-generation GLP-1 drugs that may have an even greater impact on brain health
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Learn how BPC157a powerful healing peptide praised by Andrew Huberman and Gary Breckamay help repair ligaments, reduce inflammation, and restore movement naturally
Report the product to the FDA MedWatch program at www.fda.gov/medwatch or by calling 1-800-FDA-1088
Competitive pressures exist, particularly from other GLP-1 receptor agonists and emerging dual-acting agents, but Mounjaro's established clinical data and Lilly's strategic market access provide a strong competitive advantage